Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Fulgent Genetics Inc FLGT

Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range... see more

NDAQ:FLGT - Post Discussion

Fulgent Genetics Inc > FLGT Outlook - Oracle Dispatch
View:
Post by Youhillman on Oct 17, 2020 11:44am

FLGT Outlook - Oracle Dispatch

FYI.....shares are down a bit however only for the short term

Company Outlook

FLGT has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.76 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 0.11. Fulgent Genetics Inc. FLGT also noted assets of $95.92 million at the end of the last quarter. Investors should also keep an eye on sector updates as FLGT has historically followed its peers on positive news. 

All told, Fulgent Genetics Inc. FLGT has strung together solid data and demonstrated underlying fundamentals. At its current valuation, FLGT represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels. 

Fulgent Genetics Inc. FLGT is now commanding a market cap of 860.73M and a float of 11.91M. FLGT is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of FLGT stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in FLGT, either long or short, and we have not been compensated for this article.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities